Acorda Therapeutics Inc Beta
What is the Beta of Acorda Therapeutics Inc?
The Beta of Acorda Therapeutics Inc is 0.59
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with beta similar to Acorda Therapeutics Inc
- Columbia Sportswear Co has Beta of 0.59
- REF has Beta of 0.59
- Eon Electric has Beta of 0.59
- Culp has Beta of 0.59
- B.P. Marsh & Partners PLC has Beta of 0.59
- Banco Bradesco S.A has Beta of 0.59
- Acorda Therapeutics Inc has Beta of 0.59
- Caribbean Utilities has Beta of 0.59
- Branded Legacy Inc has Beta of 0.59
- Icahn Enterprises L P has Beta of 0.59
- Universal has Beta of 0.59
- Hi Sun Technology (China) has Beta of 0.59
- Texmaco Infrastructure & has Beta of 0.59